Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAFV600E clone in a newborn affected by high-risk Langerhans cell histiocytosis.
Saved in:
| Title: | Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAFV600E clone in a newborn affected by high-risk Langerhans cell histiocytosis. |
|---|---|
| Authors: | Beneforti L; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy., Chinnici A; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy., Coniglio ML; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy., Papa MR; Department of Oncology, Hematology and Cell Therapy, AORN Santobono-Pausilipon, Naples, Italy., Punzi L; Department of Translational Medical Sciences, Section of Pediatrics, University Federico II, Naples, Italy., Sieni E; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy., De Fusco C; Department of Oncology, Hematology and Cell Therapy, AORN Santobono-Pausilipon, Naples, Italy. |
| Source: | British journal of haematology [Br J Haematol] 2024 Sep; Vol. 205 (3), pp. 1234-1237. Date of Electronic Publication: 2024 Jul 10. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
